Skip to main content

Therapies/Treatments

To overcome setbacks in combating the nation’s opioid crisis caused by the COVID-19 pandemic, policies and resources will need to be crafted in ways that address systemic inequities that have exacerbated challenges for specific populations, Acting Assistant Secretary for Mental Health and Substance Use Tom Coderre told Rx Drug Abuse & Heroin Summit attendees on Wednesday evening.
NIH director Francis S. Collins, MD, PhD, and NIDA director Nora Volkow, MD, provided Rx Summit attendees with an update on several Helping to End Addiction Long-term (HEAL) projects that include treatment interventions and research around drug use trends.
The University of Wisconsin-Madison on Tuesday announced the launch of a master’s training program in psychedelic science. The program, which will be fully online, is the first of its kind in the U.S.
A study that was presented this month at the Association of Academic Psychiatrists Annual Meeting suggests that patients being treated for pain with chronic opioid therapy are more likely to live in socially disadvantaged areas and self-report feelings of anxiety, depression and pain more frequently.
Results of a NIDA-supported pilot study released on Monday showed that collaboration between physicians and pharmacists could lead to improved medication adherence among patients being treated for opioid use disorder.
Back to Top